News | July 01, 2007

Vertebroplasty Market Growing Strong

July 2, 2007 - Analysis of the minimally invasive vertebral compression fracture (VCF) treatment market by Millennium Research Group (MRG) reveals that the U.S. market is expected to grow at double-digit rates over the next five years. This expected growth is due in part to the popularity of kyphoplasty and the emergence of new devices and competitors in the vertebroplasty market. Both kyphoplasty and vertebroplasty are minimally invasive, nonsurgical procedures, which involve the insertion of a special bone needle through the posterior soft tissues and the injection of a small amount of orthopedic cement through the needle into the vertebral body in order to relieve the pain caused by vertebral compression fractures.

"Currently, Kyphon is the largest player in the minimally invasive VCF treatment market with its kyphoplasty products. However, all the competitors including Kyphon, Stryker, ArthroCare, Cardinal Health, and Cook continue to improve the safety, efficacy, and ease-of-use of their vertebroplasty products," said Kevin Flewwelling, Senior Analyst at MRG. "Furthermore, newer competitors like Medtronic Spinal and Biologics, Spine Wave, and Spineology are providing practitioners new treatment alternatives to choose from."

For more information:

Related Content

Riverain Technologies Issued U.S. Patent for Vessel Suppression Technology
News | Computed Tomography (CT) | June 14, 2018
Riverain Technologies announced that the United States Patent and Trademark Office (USPTO) has awarded the company a...
FDA Issues Proposed Order to Reclassify Certain Radiological Medical Image Analyzers
News | Computer-Aided Detection Software | June 01, 2018
The U.S. Food and Drug Administration (FDA) is issuing a proposed order to reclassify certain radiological medical...
Median Technologies and the Nice University Hospital to Use AI in Lung Cancer Screening
News | Artificial Intelligence | March 15, 2018
March 15, 2018 – Median Technologies, the industry-leading Imaging Phenomics Company and the Nice University Hospital
FDA Clears First AI-Powered Clinical Decision Support Software for Stroke
Technology | Clinical Decision Support | February 14, 2018
The U.S. Food and Drug Administration (FDA) announced marketing clearance for Viz.AI’s Contact application, the first ...
Transpara Deep Learning Software Matches Experienced Radiologists in Mammogram Reading
News | Computer-Aided Detection Software | January 12, 2018
Deep learning and artificial intelligence improves the efficiency and accuracy of reading mammograms, according to...
Videos | Artificial Intelligence | December 19, 2017
A post-game roundup by ITN Contributing Editor Greg Freiherr and ITN Editor Dave Fornell on the key trend of artifici
iCAD's PowerLook Tomo Detection Experiences Growing Adoption
News | Mammography | December 14, 2017
December 14, 2017 — iCAD Inc.
Infervision Launches AI Platform to Help Radiologists Diagnose Stroke Faster
Technology | Computed Tomography (CT) | November 28, 2017
Infervision is introducing what it calls the first and only artificial intelligence (AI) platform to help radiologists...
Kansas City Radiology Center Employs iCAD PowerLook Tomo Detection for DBT
News | Computer-Aided Detection Software | November 10, 2017
November 10, 2017 — Imaging for Women, a leading radiology center in Kansas City, Mo., announced it is now using iCAD
Overlay Init